Labshake search
Citations for Tocris :
351 - 400 of 1830 citations for 7 Bromo 2 3 4 5 tetrahydro 1H benzo e 1 4 diazepine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 3 dpf zebrafish were paralysed using α-bungarotoxin (1 mg/ml, Tocris) and embedded in 1.2% low melting point agarose ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3-Deazaneplanocin A hydrochloride (DZN; 1 µg/dose in DMSO; Tocris). Tamoxifen (Sigma ...
-
bioRxiv - Cell Biology 2019Quote: ... 10µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris), and 50µM D-(-)-2-amino-5-phosphonopentanoic (D-AP5 or APV ...
-
bioRxiv - Neuroscience 2021Quote: ... MO]) supplemented with 7–8 µM CHIR 99021 (Tocris), 2 mL per well ...
-
bioRxiv - Cell Biology 2021Quote: ... MLCK inhibitor ML-7 (4310) was purchased from Tocris. Alexa 647-phalloidin and Alexa 350-phalloidin were purchased from ThermoFisher/LifeTechnologies ...
-
bioRxiv - Cell Biology 2020Quote: ... N2B27 (1-5% KSR) base media was supplemented with 1 µM PD0325901 (Tocris 4192); 3 µM CHIR99021 (Tocris 4423) ...
-
bioRxiv - Genomics 2020Quote: ... supplemented with SMAD inhibitors (DMH-1 2 μM Tocris, Cat. ...
-
bioRxiv - Neuroscience 2020Quote: ... placed in an aCSF-filled borosilicate glass pipette (3-5 MΩ) in the presence of 6,7-Dinitroquinoxaline-2,3-dione (DNQX; 10 μM; Tocris #14A/166549).
-
bioRxiv - Neuroscience 2023Quote: Pharmacological inhibition of AQP4 was achieved using TGN-020 (N-1,3,4-thiadiazol-2-yl-3-pyridinecarboxamide, Tocris Bioscience, UK). Unless otherwise stated ...
-
bioRxiv - Developmental Biology 2021Quote: ... Neural progenitors were briefly washed (with DMEM/F12) and were then treated with CDM2 basal media supplemented with CHIR99021 (4 μM; Tocris), SB-505124 (2 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... we used a cocktail of the mGluR-4 antagonist [0.5 mM MSOP: (RS)-α-methylserine-O-phosphate obtained from Tocris Biosciences] with either umami at 300 mM or MSGa at 600 mM ...
-
bioRxiv - Cancer Biology 2022Quote: ... and plated at 60,000 cells/cm2 in N2B27 medium supplemented with 20 ng/ml of FGF2 (Cat# 233-FB/CF, R&D) and 4 μM of CHIR 99021 (Cat# 4423, Tocris) and 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... Cells were then rinsed with 3x with PBS before fixation with 4% paraformaldehyde in PBS with 10 μg/ml Hoechest 33342 (Tocris) for 30 min at RT ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Cell Biology 2024Quote: ... bEnd.3 cells were treated with either 3-methyladenine (3-MA, #1292 Tocris, MN, USA) or rapamycin (Rapa ...
-
bioRxiv - Neuroscience 2019Quote: ... 7-dinitroquinoxaline-2,3-dione (DNQX, Tocris, 50 μM final concentration) or cyano-7-nitroquinoxaline-2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 25 μM ML-7 (Tocris, myosin light-chain kinase inhibitor), 500 μM carbenoxolone (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... CaM binding buffer was supplemented with 100μM W-7 (Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2023Quote: ... Ketanserin tartrate (Tocris Biosciences, CAS 83846-83-7; 1.5mg/kg), MDL100907 (volinanserin ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... supplemented with 100 ng/mL Activin A (R&D, Minneapolis, MN, USA) and 3–5 µM CHIR99021 (Tocris Bioscience, Bristol, UK) (differentiation day 0 ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells which efficiently depleted WAPL were identified using confocal microscopy and Western blotting after treatment of the cells with 1 µM dTAG-7 (Tocris, 6912) for 3 h ...
-
bioRxiv - Neuroscience 2023Quote: ... maneuvered adjacent to the capillary under study and pressurized injections (200–300 ms, 7 ± 1 PSI) of 100 nM T-peptide (Tocris, USA) with tetramethylrhodamine isothiocyanate (TRITC ...
-
bioRxiv - Neuroscience 2022Quote: ... cells were incubated for 1 h with 5 µM GsMTx4 (Tocris) or 15 and 30 min with 1 µM soluble Aβ1-42 (Bachem ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC Labs B-1408 ...
-
bioRxiv - Neuroscience 2020Quote: ... ACSF of similar composition to the normal ACSF but with increased concentration (4 mM) of MgCl2 and CaCl2 and supplemented with 100μM MNI-caged glutamate (Tocris Bioscience, UK) for glutamate uncaging experiments ...
-
bioRxiv - Neuroscience 2022Quote: ... where they were immobilized under a nylon mesh (Smart Ephys, SHD-26GH/10) and paralyzed by injecting 0.5 nL of bungarotoxin at 0.5 mM (Tocris, #110.32-79-4) in the trunk musculature ...
-
bioRxiv - Neuroscience 2023Quote: ... the α7 nAChR specific agonist PNU 282987 (1.6 μg total dose; 0.2 μL volume of 4 μg/μL per side; PNU 282987, Tocris, Ellisville, MO, USA), or vehicle (artificial cerebrospinal fluid [aCSF] or 50/50% aCSF/dimethylsulfoxide [DMSO] ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing rates of individual channels were compared before and after treatment with potassium channel blocker 4-AP (50 μM; Tocris, 0940), sodium channel blocker TTX (1 μM ...
-
bioRxiv - Physiology 2021Quote: ... CHO-K1 cells were transfected with cDNAs encoding for hFGF23-V5 and PCs in the ratio of 5:1 and 24 hours later pretreated for 5 hours with Dec-RVKR-CMK (50 μM; Tocris) or D6R (20 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460, Tocris) were prepared as 10 mM stocks dissolved in distilled water ...
-
bioRxiv - Cancer Biology 2021Quote: ... the positive control consisted of a treatment with 1 μM 3-AP (#2251; Tocris) for 72 h.
-
bioRxiv - Developmental Biology 2023Quote: ... but on day 3 medium was changed for LY (1 µM LPA (Tocris, 3854) and 10 µM ROCKi Y27632 ...
-
bioRxiv - Systems Biology 2020Quote: ... On Day 3 we changed the medium to RPMI + 2% B-27 (minus insulin) + 1uM Xav 939 (Tocris Bioscience, cat. 3748) and incubated the cells for 48 hours ...
-
bioRxiv - Cell Biology 2021Quote: ... 20 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris Bioscience) and 50 μM D ...
-
bioRxiv - Cell Biology 2022Quote: ... animals received 7 intraperitoneal injection of 1mg/kg quinpirole (Quin; Tocris) dissolved in 0.9% saline every 72 hours ...
-
bioRxiv - Neuroscience 2019Quote: ... 50µM 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 µM, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid (DL-AP5 ...
-
bioRxiv - Neuroscience 2024Quote: Commercially available (±)-7-hydroxy-DPAT HBr (Tocris; 50 mg, 0.15 mmol) was washed with saturated NaHCO3 aqueous solution and extracted with DCM ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Neuroscience 2023Quote: ... was selected by qualifying the presence of innervated cancer spheroids at various heights within the gel layer before stimulation with either 4 µM Bradykinin (Tocris/Biotechne, #3004) or 1 µM Capsaicin (Tocris/Biotechne ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Cell Biology 2021Quote: ... AKT (20 μM MK2206, Cayman Biochemicals #1032350-13-2) and myosin ATPase activity inhibitor (5 μM Blebbistatin, Tocris #1852).
-
bioRxiv - Neuroscience 2023Quote: ... cultures were treated with 1-2 μM CHIR 98014 (Tocris #6695) as described in (44 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... The final concentration of the compounds was 25 μM and E-64D (Tocris, 4545) was used in some of the wells as a control for infection inhibition ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX disodium salt, Catalog #1045, Tocris), (R)-Baclofen (Catalog #0796 ...
-
bioRxiv - Neuroscience 2019Quote: ... 20 µM 7-nitro-2,3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile (CNQX; Tocris), and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5 ...